Back
Roundhill GLP-1 & Weight Loss ETF Vs. First Trust Nasdaq Pharmaceuticals ETF Industry Stock Comparison
Sell
32
OZEM
Roundhill GLP-1 & Weight Loss ETF
Last Price:
26.57
Seasonality Move:
--
Sell
49
FTXH
First Trust Nasdaq Pharmaceuticals ETF
Last Price:
28.34
Seasonality Move:
6.3%
Sell
32
Roundhill GLP-1 & Weight Loss ETF (OZEM)
is a Sell
Is Roundhill GLP-1 & Weight Loss ETF a Buy, Sell or Hold?
- The current Roundhill GLP-1 & Weight Loss ETF [OZEM] share price is $26.90. The Score for OZEM is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- OZEM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
First Trust Nasdaq Pharmaceuticals ETF (FTXH)
is a Sell
Is First Trust Nasdaq Pharmaceuticals ETF a Buy, Sell or Hold?
- The current First Trust Nasdaq Pharmaceuticals ETF [FTXH] share price is $28.52. The Score for FTXH is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- FTXH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
OZEM Stock Price Chart
What is Roundhill GLP-1 & Weight Loss ETF's stock price today?
-
The Roundhill GLP-1 & Weight Loss ETF share price today is $26.90
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OZEM is experiencing selling pressure, which indicates risk of future bearish movement.
FTXH Stock Price Chart
What is First Trust Nasdaq Pharmaceuticals ETF's stock price today?
-
The First Trust Nasdaq Pharmaceuticals ETF share price today is $28.52
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FTXH is experiencing selling pressure, which indicates risk of future bearish movement.
OZEM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.26 | Sell |
Relative Strength Index (14 RSI): | 33.49 | Sell |
Chaikin Money Flow: | -31918 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (27.47 - 28.75) | Sell |
Bollinger Bands (100): | (26.81 - 28.53) | Sell |
FTXH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.12 | Sell |
Relative Strength Index (14 RSI): | 51.08 | Buy |
Chaikin Money Flow: | -2412 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (28.2 - 28.68) | Buy |
Bollinger Bands (100): | (27.77 - 29.13) | Buy |
OZEM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.56 | Sell |
20-day SMA: | 28.11 | Sell |
50-day SMA: | 28.11 | Sell |
200-day SMA: | 0 | Buy |
8-day EMA: | 27.47 | Sell |
20-day EMA: | 27.84 | Sell |
50-day EMA: | 27.91 | Sell |
200-day EMA: | 8.28 | Buy |
FTXH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.3 | Buy |
20-day SMA: | 28.44 | Buy |
50-day SMA: | 28.76 | Sell |
200-day SMA: | 27.79 | Buy |
8-day EMA: | 28.33 | Buy |
20-day EMA: | 28.42 | Buy |
50-day EMA: | 28.53 | Sell |
200-day EMA: | 27.85 | Buy |
Roundhill GLP-1 & Weight Loss ETF Earnings Growth & OZEM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
First Trust Nasdaq Pharmaceuticals ETF Earnings Growth & FTXH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Roundhill GLP-1 & Weight Loss ETF Technical Analysis
Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
First Trust Nasdaq Pharmaceuticals ETF Technical Analysis
Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |